➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
McKinsey
Mallinckrodt
Baxter
AstraZeneca

Last Updated: June 24, 2021

DrugPatentWatch Database Preview

PRIMATENE MIST Drug Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Primatene Mist, and when can generic versions of Primatene Mist launch?

Primatene Mist is a drug marketed by Armstrong Pharms and Wyeth Cons and is included in two NDAs. There is one patent protecting this drug.

The generic ingredient in PRIMATENE MIST is epinephrine. There are twenty-one drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the epinephrine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Primatene Mist

A generic version of PRIMATENE MIST was approved as epinephrine by BELCHER on July 29th, 2014.

  Try Before You Buy

US Patents and Regulatory Information for PRIMATENE MIST

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Armstrong Pharms PRIMATENE MIST epinephrine AEROSOL, METERED;INHALATION 205920-001 Nov 7, 2018 OTC Yes Yes   Try Before You Buy   Try Before You Buy Y   Try Before You Buy
Armstrong Pharms PRIMATENE MIST epinephrine AEROSOL, METERED;INHALATION 205920-001 Nov 7, 2018 OTC Yes Yes   Try Before You Buy   Try Before You Buy   Try Before You Buy
Wyeth Cons PRIMATENE MIST epinephrine AEROSOL, METERED;INHALATION 016126-001 Approved Prior to Jan 1, 1982 DISCN No No   Try Before You Buy   Try Before You Buy   Try Before You Buy
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
McKinsey
Moodys
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.